ALK vs. PXS, CLCO, ICON, PAA, GEL, MMP, AAL, CCL, SAVE, and GNK
Should you be buying Alkemy Capital Investments stock or one of its competitors? The main competitors of Alkemy Capital Investments include Provexis (PXS), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), Carnival Co. & (CCL), Savannah Energy (SAVE), and Greene King (GNK). These companies are all part of the "transportation" industry.
Alkemy Capital Investments vs.
Alkemy Capital Investments (LON:ALK) and Provexis (LON:PXS) are both small-cap financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, community ranking, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.
In the previous week, Alkemy Capital Investments' average media sentiment score of 0.00 equaled Provexis'average media sentiment score.
Provexis has higher revenue and earnings than Alkemy Capital Investments. Provexis is trading at a lower price-to-earnings ratio than Alkemy Capital Investments, indicating that it is currently the more affordable of the two stocks.
Alkemy Capital Investments has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Alkemy Capital Investments' return on equity of 181.08% beat Provexis' return on equity.
1.5% of Alkemy Capital Investments shares are owned by institutional investors. Comparatively, 7.9% of Provexis shares are owned by institutional investors. 43.7% of Alkemy Capital Investments shares are owned by company insiders. Comparatively, 21.6% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Alkemy Capital Investments has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Provexis has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.
Alkemy Capital Investments received 92 more outperform votes than Provexis when rated by MarketBeat users. Likewise, 76.88% of users gave Alkemy Capital Investments an outperform vote while only 64.21% of users gave Provexis an outperform vote.
Summary
Alkemy Capital Investments beats Provexis on 7 of the 12 factors compared between the two stocks.
Get Alkemy Capital Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALK and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alkemy Capital Investments Competitors List
Related Companies and Tools
This page (LON:ALK) was last updated on 5/21/2025 by MarketBeat.com Staff
Buy ALK Stock Free ALK Stock Alerts